These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 957110)

  • 1. Pharmacokinetic studies of pentylenetetrazol in dogs.
    Jun HW
    J Pharm Sci; 1976 Jul; 65(7):1038-41. PubMed ID: 957110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative GLC determination of pentylenetetrazol in biological fluids.
    Jun HW; Iturrian WB; Stewart JT; Lee BH
    J Pharm Sci; 1975 Nov; 64(11):1843-6. PubMed ID: 1195116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorpheniramine. II. Effect of the first-pass metabolism on the oral bioavailability in dogs.
    Athanikar NK; Chiou WL
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):383-96. PubMed ID: 512844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
    Yakatan GJ; Maness DD; Scholler J; Johnston JT; Novick WJ; Doluisio JT
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity.
    McAinsh J; Smith RP; Ferguson RA
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicokinetics of methyl paraoxon in the dog.
    De Schryver E; De Reu L; Belpaire F; Willems J
    Arch Toxicol; 1987 Feb; 59(5):319-22. PubMed ID: 3579595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prazosin first-pass metabolism and hepatic extraction in the dog.
    Rubin P; Yee YG; Anderson M; Blaschke T
    J Cardiovasc Pharmacol; 1979; 1(6):641-7. PubMed ID: 94630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and metabolic disposition of p-chloro-m-xylenol (PCMX) in dogs.
    Dorantes A; Stavchansky S
    Pharm Res; 1992 May; 9(5):677-82. PubMed ID: 1608902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
    Sponer G; Kühnle HF; Strein K; Bartsch W; Endele R; Dietmann K
    J Pharmacol Exp Ther; 1984 Jan; 228(1):235-9. PubMed ID: 6694105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
    Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T
    Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
    Straehl P; Galeazzi RL; Soliva M
    Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-pass metabolism of nomifensine in dogs.
    Lindberg R; Sellman R; Iisalo E
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):21-5. PubMed ID: 4029216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration.
    Roncari G; Ziegler WH; Guentert TW
    Br J Clin Pharmacol; 1986 Oct; 22(4):421-8. PubMed ID: 3094572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and disposition of trifluoperazine in the rat. II. Kinetics after oral and intravenous administration in acutely and chronically treated animals.
    Schmalzing G
    Drug Metab Dispos; 1977; 5(2):104-15. PubMed ID: 15802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of prazosin.
    Jaillon P
    Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.